Wave Life Sciences Ltd. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 38.2M | 17.2M | 7.6M | 8.7M | 9.2M | 83.7M | -7.7M | 19.7M |
| Cost of Goods Sold | 0 | 2.3M | 0 | 2.2M | 2.2M | 0 | 0 | 0 |
| Gross Profit | 38.2M | 15.0M | 7.6M | 6.5M | 7.0M | 83.7M | -7.7M | 19.7M |
| R&D Expenses | 47.4M | 52.8M | 45.9M | 43.5M | 40.6M | 44.6M | 41.2M | 40.4M |
| Operating Expenses | 69.5M | 71.5M | 64.0M | 59.3M | 56.8M | 60.8M | 56.2M | 54.7M |
| Operating Income | -31.3M | -56.5M | -56.4M | -52.8M | -49.8M | 23.0M | -63.9M | -35.0M |
| Other Income / Gains | 5.2M | 3.3M | 2.5M | 2.3M | 2.9M | 6.3M | 2.1M | 2.1M |
| Net Income | -26.1M | -53.2M | -53.9M | -50.5M | -46.9M | 29.3M | -61.8M | -32.9M |
| EPS (Diluted) | -0.13 | -0.30 | -0.32 | -0.31 | -0.29 | 0.18 | -0.47 | -0.25 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 1.00 | 0.869 | 1.00 | 0.748 | 0.764 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 22.1M | 20.9M | 18.1M | 18.0M | 18.4M | 16.1M | 15.0M | 14.3M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 22.1M | 20.9M | 18.1M | 18.0M | 18.4M | 16.1M | 15.0M | 14.3M |
| Other Expenses | 0 | -2.3M | 0 | -2.2M | -2.2M | 0 | 0 | 0 |
| Cost And Expenses | 69.5M | 73.7M | 64.0M | 61.5M | 59.0M | 60.8M | 56.2M | 54.7M |
| Interest Income | 5.3M | 3.1M | 2.2M | 2.4M | 2.9M | 3.7M | 1.8M | 2.1M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 2.3M | 2.3M | 2.2M | 2.2M | 2.2M | 2.2M | 2.2M | 2.2M |
| Ebitda | -23.8M | -50.9M | -51.6M | -48.3M | -44.7M | 31.4M | -59.6M | -30.8M |
| Ebitdaratio | -0.622 | -2.953 | -6.785 | -5.549 | -4.873 | 0.375 | 7.767 | -1.562 |
| Operating Income Ratio | -0.818 | -3.274 | -7.407 | -6.065 | -5.428 | 0.274 | 8.327 | -1.777 |
| Income Before Tax | -26.1M | -53.2M | -53.9M | -50.5M | -46.9M | 29.3M | -61.8M | -32.9M |
| Income Before Tax Ratio | -0.682 | -3.084 | -7.078 | -5.802 | -5.109 | 0.349 | 8.048 | -1.672 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -0.682 | -3.084 | -7.078 | -5.802 | -5.109 | 0.349 | 8.048 | -1.672 |
| Epsdiluted | -0.13 | -0.30 | -0.32 | -0.31 | -0.29 | 0.17 | -0.47 | -0.25 |
| Weighted Average Shs Out | 200.2M | 180.2M | 167.7M | 164.0M | 162.5M | 161.5M | 131.4M | 129.5M |
| Weighted Average Shs Out Dil | 200.2M | 180.2M | 167.7M | 164.0M | 162.5M | 172.3M | 132.6M | 129.5M |